Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Mucosal immunization with DNA vaccines.

M J McCluskie1, H L Davis

  • 1Loeb Health Research Institute at the Ottawa Hospital, 725 Parkdale Avenue, Ottawa K1Y 4E9, Canada.

Microbes and Infection
|December 28, 1999
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Intramuscular and intradermal injection of DNA vaccines in mice and primates.

Methods in molecular medicine·2011
Same author

DNA-Based Immunization of Neonatal Mice.

Methods in molecular medicine·2011
Same author

Intramuscular injection of DNA vaccines in fish.

Methods in molecular medicine·2011
Same author

Immunostimulatory CpG motifs and DNA vaccines.

Methods in molecular medicine·2011
Same author

Mucosal immunization with DNA vaccines.

Methods in molecular medicine·2011
Same author

CPG 7909 adjuvant plus hepatitis B virus vaccination in HIV-infected adults achieves long-term seroprotection for up to 5 years.

Clinical infectious diseases : an official publication of the Infectious Diseases Society of America·2008
Same journal

The extent of monocytic myeloid suppressor cells induction determines the host immune response during Mycobacterium avium infection.

Microbes and infection·2025
Same journal

Culture-attenuated pathogenic Leptospira lose the ability to survive complement lytic activity due to decreased C4BP uptake.

Microbes and infection·2025
Same journal

Exploring the link between genetically predicted plasma cathepsins and COVID-19: A mendelian randomization study of susceptibility and severity.

Microbes and infection·2025
Same journal

Laboratory parameters and serum tube agglutination test as markers for brucellosis treatment response.

Microbes and infection·2025
Same journal

Corrigendum to "Lactococcus lactis and Bifidobacterium longum attenuate Clostridioides difficile- or Clostridium symbiosum-induced colitis and depression/anxiety-like behavior in male mice" [Microb Infect 27(7) (2025) 105560].

Microbes and infection·2025
Same journal

Disrupted Microbiome-Metabolome networks underlie gut barrier and immune imbalance in severe fever with thrombocytopenia syndrome.

Microbes and infection·2025
See all related articles

DNA vaccines show promise for inducing strong immune responses. This review focuses on using DNA vaccines for mucosal immunization to enhance protection against mucosal pathogens.

Area of Science:

  • Immunology
  • Vaccinology
  • Molecular Biology

Background:

  • DNA vaccines are known to elicit robust humoral and cellular immunity in various animal models.
  • Parenteral administration is the most common route for DNA vaccines.
  • Mucosal pathogens pose a significant challenge, necessitating alternative immunization strategies.

Purpose of the Study:

  • To review the application of DNA vaccines for inducing mucosal immunity.
  • To explore the potential of mucosal DNA vaccination against mucosal pathogens.

Main Methods:

  • Literature review of studies on DNA vaccines and mucosal immunity.
  • Analysis of research focusing on parenteral versus mucosal administration of DNA vaccines.
  • Synthesis of findings related to immune responses induced by mucosal DNA vaccination.

Related Experiment Videos

Main Results:

  • DNA vaccines can be effectively utilized for mucosal immunization.
  • Mucosal immunization routes may offer enhanced protection against mucosal pathogens compared to parenteral routes.
  • Specific strategies for optimizing DNA vaccine delivery and immunogenicity at mucosal sites are discussed.

Conclusions:

  • Mucosal DNA vaccination represents a promising strategy for developing vaccines against mucosal pathogens.
  • Further research into optimizing mucosal DNA vaccine platforms is warranted.
  • This approach holds potential for improved disease prevention at mucosal surfaces.